Fact CheckerSign in

NCT05189847Completed

Clinical Register Studying the therApeutic Patient Population With Multifocal Atherosclerosis

Clinical Register Studying the therApeutic Patient Population With Multifocal Atherosclerosis in the Russian Federation and Eurasian Countries

Source: ClinicalTrials.gov · Last updated 26 Jun 2024

Brief summary (registry, in English)

Аn international, multicenter, non-interventional real-life clinical practice Register studying the Actual therapeutic patient population with Multifocal Atherosclerosis in the Russian Federation and Eurasian countries

Status (registry)
Completed
Study type
Observational
Enrollment
3059 (actual)
First submitted
28 Dec 2021
Start date
1 Feb 2022
Primary completion date
31 Jan 2024
Lead sponsor
Eurasian Association of Therapists
NCT number
NCT05189847

What you commit to

  • Study type: Observational
  • Participants enrolled: 3059
  • From 1 Feb 2022 to the primary completion date, 31 Jan 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Life expectancy less than 1 year;
  • Patient refusal to participate in the Register

Who the study is looking for

  • Men or women aged 18 and older at the time of data registration; Presence of 2 or more of the following factors
    • Coronary arteries atherosclerosis (atherosclerosis revealed by means of coronary angiography and/or a history of type I myocardial infarction and/or elective PCI and/or CABG and/or angina pectoris with ischemia according to stress test results, history of CHD);
    • Lower extremity arteries atherosclerosis (atherosclerotic plaques revealed by ultrasound, and/or ABI \<0.9, and/or a history of revascularization, and/or a history of amputation associated due to chronic lower extremities arterial insufficiency);
    • Atherosclerosis of brachiocephalic arteries or renal arteries (presence of atherosclerotic plaques according to US data and/or history of revascularization and/or history of atherothrombotic stroke or TIA in the absence of known AF);
    • Atherosclerosis of renal arteries or abdominal aorta (presence of atherosclerotic plaques according to US data and/or history of revascularization).
    • Presence of one or more of the following atherosclerotic risk factors:
  • Anamnestic data on dyslipidemia with LDL cholesterol levels above 4.9 mmol/L or total cholesterol levels above 8.0 mmol/L;
  • Presence of confirmed familial hypercholesterolemia;
  • Current smoker status or history of smoking;
  • Overweight (BMI≥ 25 kg/m2);
  • Presence of arterial hypertension;
  • Presence of established type 2 diabetes mellitus;
  • Presence of an established diagnosis of prediabetes;
  • Presence of CKD stage 3a and higher (GFR \<60 ml / min / 1.73 m2).

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Eurasian Association of Therapists
Coordinator of this site? Confirm its status
MoscowRussiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.